Vienna, Austria, [November 13, 2026] – Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and Miller School of Medicine, has achieved Accredited Centre status from the International Accreditation System for Interventional Oncology Services (IASIOS). Awarded on 7 October 2026, the four-year accreditation recognises that its interventional oncology service meets established international quality assurance requirements for the organisation and delivery of patient care.
As a National Cancer Institute-designated cancer centre, Sylvester combines cancer research, education and multidisciplinary clinical care. The accreditation recognises the work of its interventional oncology team, including Dr. Maria Del Pilar Bayona Molano, Associate Professor of Clinical Interventional Radiology at the University of Miami Miller School of Medicine.
“Achieving IASIOS accreditation reflects Sylvester’s commitment to delivering interventional oncology care that is evidence-based, coordinated and centered on patients’ specific needs,” said Dr. Bayona Molano. “This recognition validates the work of our multidisciplinary teams and the high standards we apply across every stage of the patient journey, from consultation and treatment planning through follow-up care.”
Interventional oncology uses image-guided, minimally invasive procedures to treat cancer. Its clinical role extends beyond the procedure itself: consultation helps determine whether a treatment is appropriate and how it fits into the wider cancer care plan, while clear follow-up responsibilities support continuity of care for patients and referring clinicians.
“Interventional oncology has become an essential pillar of modern cancer care, offering targeted, minimally invasive treatments that can improve outcomes and quality of life for patients. And as an academic health system, we have a responsibility not only to deliver exceptional care but also to help advance the standards that define excellence in our field,” said Dr. Stephen Solomon, Professor and Chairman of the Department of Interventional Radiology at the Miller School of Medicine. “This achievement recognizes not only clinical excellence, but also the infrastructure, collaboration and accountability required to deliver these therapies at the highest level.”
IASIOS accreditation evaluates the systems and processes that support care across the interventional oncology patient pathway. Based on the CIRSE Standards of Quality Assurance in Interventional Oncology, it examines multidisciplinary decision-making and documentation, defined clinical responsibilities, patient follow-up, complication management and continuous quality improvement. This places an emphasis on the entire service, not just the technical performance of individual procedures.
About Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and Miller School of Medicine, is the only cancer center in South Florida designated by the National Cancer Institute (NCI). Sylvester is known as South Florida’s leader in cancer research and care, offering the only academic-based phase 1 clinical trials program in the region. U.S. News & World Report has ranked Sylvester #1 in Miami, #1 in Florida and among the top 25 in the nation for cancer care. Sylvester also earned High Performing ratings in the treatment of leukemia, lymphoma and myeloma, as well as in surgeries for colon, gynecological, lung and prostate cancers. With a network of 11 facilities in South Florida and one office in Southwest Florida, Sylvester operates 16 site disease groups, including transplant and cellular therapy, classical hematology, myeloma, lymphoma, leukemia, sarcoma, neuro-oncology, endocrine tumors as well as skin, thoracic, gynecological, genitourinary, gastrointestinal, pediatric, breast and head and neck cancers.
About IASIOS
The International Accreditation System for Interventional Oncology Services (IASIOS) is an international accreditation system dedicated to medical facilities providing interventional oncology services. Based on the CIRSE Standards of Quality Assurance in Interventional Oncology, IASIOS provides a framework for facilities to evaluate and improve care across the patient pathway, with a focus on multidisciplinary collaboration, patient safety and continuous improvement. For more information, visit www.iasios.org.
Media contacts
IASIOS
Gulnara Miribayeva
Marketing and Brand Lead, IASIOS
[email protected] | +43 1 904 2003-57
Sylvester Comprehensive Cancer Center
Katie Camero
Assistant Director, Medical Communications and Media Relations
[email protected]

